Abstract
Background/Aim: Ovarian metastases from colorectal carcinoma (CRC) are rare but have significant clinical implications, often resembling primary ovarian tumors. An incorrect diagnosis can result in delayed systemic therapy and surgical planning.
Case Report: A 56-year-old postmenopausal woman presented with right lower quadrant pain and postmenopausal bleeding. Pelvic ultrasound and computed tomography (CT) scans demonstrated a large, complex adnexal mass with thickening of the ascending colonic wall. She underwent diagnostic laparoscopy and subsequent total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy, tumor debulking, and right hemicolectomy. The postoperative pathology revealed a moderately differentiated adenocarcinoma of the cecum, with bilaterally metastatic involvement of the ovaries, omentum, peritoneal surfaces, and liver serosa. Immunohistochemistry confirmed the colonic origin (CDX2+, CK20+, CK7−). She was diagnosed with stage IVc (pT4aN2aM1c) colon adenocarcinoma and subsequently started on systemic treatment with mFOLFIRINOX with bevacizumab.
Conclusion: This case highlights the diagnostic challenge of distinguishing between primary ovarian carcinoma and metastatic colorectal adenocarcinoma, underscoring the need for multidisciplinary collaboration and immunohistochemical confirmation to inform treatment decisions.
- Colorectal cancer
- ovarian metastasis
- Krukenberg tumor
- CDX2
- immunohistochemistry
- right-sided colon cancer
- metastatic adenocarcinoma
- mFOLFIRINOX
- bevacizumab
- adnexal mass
- peritoneal metastasis
- Received February 2, 2026.
- Revision received February 24, 2026.
- Accepted February 26, 2026.
- Copyright © 2026 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.






